{
     "PMID": "26712273",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20161017",
     "LR": "20161230",
     "IS": "1873-3492 (Electronic) 0009-8981 (Linking)",
     "VI": "453",
     "DP": "2016 Jan 30",
     "TI": "Simultaneous determination of 8 neurotransmitters and their metabolite levels in rat brain using liquid chromatography in tandem with mass spectrometry: Application to the murine Nrf2 model of depression.",
     "PG": "174-81",
     "LID": "10.1016/j.cca.2015.12.023 [doi] S0009-8981(15)30092-9 [pii]",
     "AB": "Analysis of neurotransmitters and their metabolites is useful for the diagnosis of central nervous system diseases. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with protein precipitation was developed to monitor levels of adrenaline (AD), noradrenaline (NA), glutamic acid (Glu), gamma-aminobutyric acid (GABA), dopamine (DA), 5-hydroxytryptamine (5-HT), 5-hydroxyindole acetic acid (5-HIAA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) in rat brain tissue. Isoprenaline was used as an internal standard (IS). Neurotransmitters and metabolites were eluted with a reverse phase column under gradient conditions through a mobile phase consisting of 0.2% formic acid water solution/acetonitrile. The compounds were detected and quantified by LC-MS/MS with positive or negative electrospray ionization, which operates in multiple-reaction monitoring mode. The method was linear or polynomial (R(2)>0.99) for AD, NA, Glu, GABA, DA, 5-HT, 5-HIAA, and MHPG in the range of 0.25-200, 0.5-200, 250-20,000, 250-20,000, 0.25-200, 10-3000, 1-50, and 1-50ng/mL, respectively. The validation assays for accuracy and precision, matrix effect, extraction recovery, stability and carry-over of the samples for neurotransmitters and metabolites were consistent with the requirements of regulatory agencies. The method enables rapid quantification of neurotransmitters and their metabolites and has been applied in the nuclear factor (erythroid 2-derived)-like 2 (Nrf2) knockout mouse model of depression.",
     "CI": [
          "Copyright (c) 2015 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Wojnicz, Aneta",
          "Avendano Ortiz, Jose",
          "Casas, Ana I",
          "Freitas, Andiara E",
          "G Lopez, Manuela",
          "Ruiz-Nuno, Ana"
     ],
     "AU": [
          "Wojnicz A",
          "Avendano Ortiz J",
          "Casas AI",
          "Freitas AE",
          "G Lopez M",
          "Ruiz-Nuno A"
     ],
     "AD": "Instituto-Fundacion Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain; Servicio de Farmacologia Clinica, Instituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain; Department of Pharmacology, CARIM, and Maastricht Institute for Advanced Studies, Maastricht University, The Netherlands. Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain; Center of Biological Sciences, Universidade Federal de Santa Catarina, Campus Universitario, Trindade, Florianopolis, Brazil. Instituto-Fundacion Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Departamento de Farmacologia y Terapeutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain. Instituto-Fundacion Teofilo Hernando, Universidad Autonoma de Madrid, Madrid, Spain; Servicio de Farmacologia Clinica, Instituto de Investigacion Sanitaria, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain. Electronic address: anaruiznuno@yahoo.es.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151219",
     "PL": "Netherlands",
     "TA": "Clin Chim Acta",
     "JT": "Clinica chimica acta; international journal of clinical chemistry",
     "JID": "1302422",
     "RN": [
          "0 (NF-E2-Related Factor 2)",
          "0 (Neurotransmitter Agents)",
          "0 (Nfe2l2 protein, mouse)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Blood Chemical Analysis/*methods",
          "Calibration",
          "Chromatography, Liquid",
          "Depression/*blood/genetics",
          "Disease Models, Animal",
          "Gene Knockout Techniques",
          "Hippocampus/metabolism",
          "Linear Models",
          "Male",
          "Mice",
          "NF-E2-Related Factor 2/*deficiency/*genetics",
          "Neurotransmitter Agents/*blood/*metabolism",
          "Rats",
          "*Tandem Mass Spectrometry",
          "Time Factors"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Liquid chromatography-tandem mass spectrometry",
          "Metabolites",
          "Neurotransmitters",
          "Protein precipitation",
          "Rat brain"
     ],
     "EDAT": "2015/12/30 06:00",
     "MHDA": "2016/10/19 06:00",
     "CRDT": [
          "2015/12/30 06:00"
     ],
     "PHST": [
          "2015/08/17 00:00 [received]",
          "2015/12/04 00:00 [revised]",
          "2015/12/18 00:00 [accepted]",
          "2015/12/30 06:00 [entrez]",
          "2015/12/30 06:00 [pubmed]",
          "2016/10/19 06:00 [medline]"
     ],
     "AID": [
          "S0009-8981(15)30092-9 [pii]",
          "10.1016/j.cca.2015.12.023 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Clin Chim Acta. 2016 Jan 30;453:174-81. doi: 10.1016/j.cca.2015.12.023. Epub 2015 Dec 19.",
     "term": "hippocampus"
}